EP2370359

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Application Number
EP09805783A
Filing Date
Dec 22, 2009
Status
Patent Maintained As Amended
Apr 15, 2022
Grant Date
May 18, 2022
External Links
Slate, Register

Biblio Summary

The patent EP2370359B2 was granted on May 18, 2022 by Centre National De La Recherche Scientifique The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.Oct 29, 2018 N.A.

The table below shows the patents of Centre National De La Recherche Scientifique that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3152234Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T LymphocytesJun 26, 20241
EP3911354Aav-Mediated Gene Therapy Restoring The Otoferlin GeneApr 3, 20244
EP3066203New Alzheimer'S Disease Animal ModelNov 8, 20232